Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-acting Injectable Cabotegravir for PrEP”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableNot Yet RecruitingNCT07516548
What this trial is testing

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

Who this might be right for
HIV InfectionsContraceptionDrug-drug Interaction+2 more
University of Alabama at Birmingham 105
Not applicableStudy completedNCT05799339
What this trial is testing

Optimizing CAB-LA as PrEP for Women Who Inject Drugs

Who this might be right for
HIV InfectionsOpioid UseTrauma, Psychological
Alexis Roth 144
Not applicableLooking for participantsNCT07221747
What this trial is testing

PathToScale: The PERSIST Trial

Who this might be right for
Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP
Georgetown University 9,900
Post-approval studies (Phase 4)Looking for participantsNCT07199335
What this trial is testing

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Who this might be right for
HIVSubstance Use Disorder (SUD)Injection Drug Use
Massachusetts General Hospital 100
Post-approval studies (Phase 4)Study completedNCT05514509
What this trial is testing

A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

Who this might be right for
HIV Infections
ViiV Healthcare 370
Large-scale testing (Phase 3)Looking for participantsNCT05515770
What this trial is testing

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir

Who this might be right for
HIV Infections
Evandro Chagas National Institute of Infectious Disease 1,200
Not applicableNot Yet RecruitingNCT07579754
What this trial is testing

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

Who this might be right for
Long-acting Injectable Cabotegravir for PrEPOral Pre-Exposure Prophylaxis (PrEP)
Johns Hopkins Bloomberg School of Public Health 384
Not applicableLooking for participantsNCT06807736
What this trial is testing

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

Who this might be right for
HIV InfectionSexual and Reproductive Health
Desmond Tutu HIV Foundation 1,800
Not applicableUnknownNCT06319105
What this trial is testing

PathToScale: An Implementation Evaluation

Who this might be right for
Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP
Georgetown University 9,900
Post-approval studies (Phase 4)Study completedNCT05374525
What this trial is testing

A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States

Who this might be right for
HIV Infections
ViiV Healthcare 287
Not applicableLooking for participantsNCT06868641
What this trial is testing

The TAIL-PrEP Study

Who this might be right for
HIV Infections
Columbia University 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06273943
What this trial is testing

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Who this might be right for
Prevention
ANRS, Emerging Infectious Diseases 322
Not applicableStudy completedNCT05867212
What this trial is testing

Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

Who this might be right for
HIV Infections
Kelley-Ross & Associates, Inc. 50